Development and feasibility testing of a time-restricted eating intervention for women living with overweight/obesity and HIV in a resource-limited setting of South Africa

Abstract Background Human Immunodeficiency Virus (HIV) and type 2 diabetes (T2D) are amongst the leading causes of death in South Africa. The preferred first-line anti-retroviral treatment contains dolutegravir (DTG), shown to increase body weight, may compound the already high rates of obesity and...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Fatima Hoosen, Majken L. Pico, Julia H. Goedecke, Joel A. Dave, Jonas S. Quist, Kristine Færch, Louise G. Grunnet, Anniza de Villiers, Jens Aagaard-Hansen, Amy E. Mendham
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2024-10-01
סדרה:	BMC Public Health
נושאים:	HIV Anti-retroviral therapy COM-B model Time-restricted eating Weight management intervention Type 2 diabetes
גישה מקוונת:	https://doi.org/10.1186/s12889-024-20228-y
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!